Back to 
Woodline Partners LP
Woodline Partners LP
LGND
Showing 0 of 2 quarters
Position history for Woodline Partners LP's holdings in LIGAND PHARMACEUTICALS INC
No. Woodline Partners exited its LGND (Ligand Pharmaceuticals) position in Q2 2020. Its Q1 2020 13F listed 20,544 shares worth $1.5M. Woodline Partners first reported LGND in Q1 2020 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.